glp-1 receptor agonist news and health: Beyond weight loss in the Ozempic era Side Effects: Endocrine Society Journals
Description
With the availability of multiple drug therapies demonstrating promising efficacy, we expect market competition to produce downward pressure on prices, most likely in the form of rebates for GLP-1s
2003 Sep;67((Pt 5)):471485
Yes, these drugs were originally developed for type 2 diabetes but are now widely used for weight management because they reliably reduce appetite and induce significant weight loss
They focused on adults with type 2 diabetes who had started either GLP-1 receptor agonists or metformin as their initial diabetes therapy
